Nippon Steel Corporation

Srikant M. Datar; Akiko  Kanno

Case | HBS Case Collection | April 2009 (Revised March 2010)

Nippon Steel Corporation

Abstract

Nippon Steel Corporation, the largest Japanese steel producer and second largest in the world faces challenges in pursuing strategy to become a true global player. Nippon Steel had long been the top Japanese company, however the emergence of a global player, Arcelor-Mittal, prompted globalization of the steel industry. The company feels the urgent need to also globalize the company by not just increasing overseas production but also making necessary changes to the company structure.

Keywords: History; Corporate Strategy; Problems and Challenges; International Accounting; Change Management; Restructuring; Competitive Strategy; Emerging Markets; Globalization; Global Strategy; Steel Industry; Japan;

Format: Print

18 pages

Educators Purchase

Citation:

Datar, Srikant M., and Akiko Kanno. "Nippon Steel Corporation." Harvard Business School Case 109-038, April 2009. (Revised March 2010.)

We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating angina). Specifically we chronicle the 1) development of the foundational procedures and technologies that provided a base for CABG; 2) early CABG operations performed in the 1960s; 3) rapid—and controversial growth—that occurred in the U.S. in the 1970s and; 4) emergence and rapid diffusion of the less invasive angioplasty alternative that slowed the growth of CABG in the last two decades of the 20th century.

We describe how Computed Tomography (CT) scanners—that combine x-rays and computers to image soft tissues of the brain and other organs—have become a widely used diagnostic tool. Specifically, we chronicle the following: 1) development of the first CT scanner (through the early 1970s); 2) rapid and enthusiastic adoption of CT scanning (until the late 1970s); 3) regulatory backlash against the perceived overuse of this expensive technology (in the 1980s); and 4) innovations that reignited growth (in the 1990s and 2000s).

We describe how a chance discovery of bacteria that infects stomach linings completely changed how physicians treat ulcers. Specifically, we chronicle how 1) two Australian physicians brought the bacterial infection to the world’s attention and challenged the conventional view that stomach acidity caused ulcers; 2) a global community of researchers helped corroborate the Australians’ findings and developed convenient tests and effective treatments; and 3) these tests and treatments were gradually, but not immediately, adopted.

Faculty & Research

Nippon Steel Corporation

Abstract

Citation:

About the Author

More from the Author

Faculty & Research

Nippon Steel Corporation

Abstract

Citation:

Related Work

About the Author

More from the Author